REGN Regeneron Pharmaceuticals
- 957.380
- +0.380+0.04%
Regeneron Pharmaceuticals News
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
